TGA Approval

SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial (388597)

ARTG ID

388597

ARTG Name

SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial

Sponsor

Boehringer Ingelheim Pty Ltd

ARTG Date

November 24, 2023

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BOEHRINGER INGELHEIM PTY LTD

https://medical-cdn.nocode.com/drug_tga/1e2e5ee0d7bcc7ad8b9b5bed991f20f9.pdf

https://medical-cdn.nocode.com/drug_tga/94306339823ef230fda5cdc4ee029572.pdf

Ingredient Name

spesolimab

Empowering clinical research with data-driven insights and AI-powered tools.

SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial (388597) - TGA 批准文号 | MedPath